ADC Therapeutics (ADCT) Research & Development (2019 - 2026)
ADC Therapeutics' Research & Development came in at $17.37 million for Q2 2026, down 42.3% from $30.09 million a year earlier and down 12.6% from the prior quarter.
Powered by 
Analysis
ADC Therapeutics (ADCT) Research & Development (2019 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, ADC Therapeutics reported Research & Development of $94.14 million, down 18.7% year-over-year.
- The Q2 2026 figure represents the lowest quarterly Research & Development in data going back to Q1 2020.
- Year-over-year, Research & Development increased in three of the last six quarters, with an average decline of 5.8%.
- The fastest year-over-year change in Research & Development over five years came in Q1 2022 (growth of 25.0%), and the weakest in Q2 2026 (a decline of 42.3%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.25 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 2.57 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 4.54 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 3.89 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 2.11 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.61 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 3.02 Bn |
| 10 | ADC Therapeutics | 192.88 Mn | -707.77 Mn | 19.74 Mn | 14.74 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 14.74 Mn |
| Jun 30, 2026 | 17.37 Mn |
| Mar 31, 2026 | 19.88 Mn |
| Dec 31, 2025 | 18.18 Mn |
| Sep 30, 2025 | 26.80 Mn |
| Jun 30, 2025 | 30.09 Mn |
| Mar 31, 2025 | 28.93 Mn |
| Dec 31, 2024 | 27.10 Mn |
| Sep 30, 2024 | 32.50 Mn |
| Jun 30, 2024 | 24.30 Mn |
| Mar 31, 2024 | 25.74 Mn |
| Dec 31, 2023 | 30.33 Mn |
| Sep 30, 2023 | 27.08 Mn |
| Jun 30, 2023 | 31.34 Mn |
| Mar 31, 2023 | 39.48 Mn |
| Dec 31, 2022 | 48.73 Mn |
| Sep 30, 2022 | 41.68 Mn |
| Jun 30, 2022 | 48.54 Mn |
| Mar 31, 2022 | 48.95 Mn |
| Dec 31, 2021 | 42.49 Mn |
API Access
ADC Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=ADCT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "ADCT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=ADCT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();